ARCHIVES

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Fewer Side Effects With IMRT Than Traditional Radiation

August 31, 2007

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006